Criteria for Selection of Patients with Atrial Fibrillation to Receive a Dual-Site ICD
Atrial fibrillation is the most common sustained tachyarrhythmia and is increasing in prevalence as the population ages [1,2]. It causes symptoms such as palpitations and dyspnea, but is also associated with stroke, heart failure, and an increasing risk of hospitalization and death. Over one-third of hospital admissions for arrhythmias are secondary to atrial fibrillation . Restoration and maintenance of normal sinus rhythm by means of cardioversion is the first treatment option for clinicians. The choice of therapeutic intervention is generally guided by the severity and duration of the patients’ symptoms and their tolerance or response to intervention.
KeywordsAtrial Fibrillation Implantable Cardioverter Defibrillator Normal Sinus Rhythm Atrial Arrhythmia Atrial Pace
Unable to display preview. Download preview PDF.
- 3.Baily D, Lehmann MH, Schumacher DN, Steinman RT, Meissner MD (1992) Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. Am J Cardiol 19:14AGoogle Scholar
- 4.Wijffels M, Kirschhof C, Boersma L, Allessie M (1994) Atrial fibrillation begets atrial fibrillation. In: Atrial fibrillation: mechanisms and therapeutic strategies. Futura, Armonk, pp 195–201Google Scholar
- 10.Carlson MD (2001)The atrial dynamic overdrive pacing trial. North American Society of Pacing and Electrophysiology, Boston, May 2001Google Scholar
- 14.Guidant METRIX Implantable Atrial Defibrillator Annual Progress Report. Guidant Inc., USA, May 2000Google Scholar
- 15.Medtronic Jewel AF 7250 Dual-Chamber Implantable Cardioverter Defibrillator System Summary of Safety and Effectiveness. Medtronic Inc., USA, 14 June 2000Google Scholar